Company Profile
Beijing Bohui Innovation Biotechnology provides the research and development, production, sale, and after-sale service of diagnostic products in China. The company offers human immunoglobulin for rabies, tetanus, hepatitis B, and intravenous injections.
Its portfolio also includes albumin, human prothrombin complex, and vaccine for rabies molecular platform, such as Automatic Real-time Fluorescent Nucleic Acid Cartridge Analyzer(BHQ-III), and GenPlex BHF-VI Nucleic Acid Chip Analyzer.
Its portfolio also includes Trace Element Analyzers, Fluorescence Immunoassay Analyzers, and Quantum Dot Analyzer, and detection kits for respiratory, intestinal, reproductive infections
Trace element testing, allergen testing, and others. Additionally, it offers mass spectrometers, plate readers, and standardized ion sources; and flash, process, and preparative purification systems.
Founded in 2001 and headquartered in Beijing, China, Beijing Bohui Innovation Biotechnology was formerly known as Beijing Bohui Innovation Biotechnology Co., Ltd. before rebranding in August 2021.